MacroGenics
MGNX
#8794
Rank
S$0.30 B
Marketcap
S$4.79
Share price
5.35%
Change (1 day)
111.06%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): S-$0.72

According to MacroGenics's latest financial reports the company's current EPS (TTM) is S-$0.73. In 2025 the company made an earnings per share (EPS) of S-$1.51 a decrease over its 2024 EPS that were of S-$1.37.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.72-52.37%
2025S-$1.5110.28%
2024S-$1.37613.33%
2023S-$0.19-92.31%
2022S-$2.50-42.14%
2021S-$4.3136.44%
2020S-$3.16-21.84%
2019S-$4.05-24.58%
2018S-$5.36675.93%
2017S-$0.69-68.05%
2016S-$2.16168.25%
2015S-$0.81-55%
2014S-$1.793400%
2013S-$0.05122-108.68%
2012S$0.5924.49%
2011S$0.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$0.97-233.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$38.26-5,342.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$20.77-2,945.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S-$3.33 356.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$1.62-322.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$5.81-896.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S-$2.78 280.70%๐Ÿ‡บ๐Ÿ‡ธ USA